Jci_page_head_homepage_01 Jci_page_head_homepage_02
Scott N. Mueller, Vijay K. Vanguri, Sang-Jun Ha, Erin E. West, Mary E. Keir, Jonathan N. Glickman, Arlene H. Sharpe, Rafi Ahmed
Published in Volume 120, Issue 7
J Clin Invest. 2010; 120(7):2508–2515 doi:10.1172/JCI40040
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Model comparing roles of hematopoietic and nonhematopoietic cells in regulating T cell responses via the PD-1/PD-L1 pathway during infection.

(A) BM-derived cells, such as APCs, upregulate PD-L1 after infection and interact with PD-1+ antigen–specific T cells, negatively regulating cell expansion and cytokine production. Interactions between CD28 on T cells and B7 (CD80 or CD86) on APC costimulates antigen-specific TCR-MHC interactions and can be inhibited by concurrent PD-1/PD-L1 interactions. PD-L1 on T cells may also interact with CD80 on APCs to deliver inhibitory signals (not shown). (B) PD-L1 is upregulated on infected nonhematopoietic cells in tissues and regulates viral clearance and immunopathology during infection.